 |
|
|
|
reason -at- fightaging -dot- org
|
|
Recent Entries
Keeping Wikipedia Spick and Span
Save, Invest or Die
The Economic Case Against Aging
David Chambers on Tomorrow's People
Pledge to Join the MPrize's Three Hundred at PledgeBank
Ageless Animals, Absent Immortality, Evolutionary Biology and Aging
Cryonics and Freedom
Searching for Articles
Regenerative Medicine for Things Other Than Aging
The Other Uses For Vitrification
The Tithonus Error, Still Hale and Hearty
Growth Hormone in the Press Again
A Couple of Items of Interest
Coming to That Time Again
5.4%?
Tissue Regeneration Article from the Life Extension Magazine
Tomorrow's People Event Underway
"Life Extension" is a Narrow Brand
A Brief Libertarian Interlude
Defending the Development of Healthy Life Extension Technologies
Archives (Monthly)
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
March 2006
February 2006
January 2006
December 2005
November 2005
October 2005
September 2005
August 2005
July 2005
June 2005
May 2005
April 2005
March 2005
February 2005
January 2005
December 2004
November 2004
October 2004
September 2004
August 2004
July 2004
June 2004
May 2004
April 2004
March 2004
February 2004
January 2004
Creative Commons
Fight Aging! is published under the Creative Commons Attribution 3.0 license. In short, this means that you are encouraged to republish and rewrite Fight Aging! content in any way you see fit, the only requirements being that you (a) link to the original, (b) attribute the author, and (c) attribute Fight Aging!.
|
 |
|
|
|
I make good use of Wikipedia as a resource, both here and in the Longevity Meme daily news; I'm usually pleasantly suprised to find that even comparatively obscure bioscience terms and references have comprehensible entries for the layman. For those unfamiliar with the concept of a large-scale wiki, it is essentially the gift economy of open source applied to reference materials. Everyone can edit, so - in theory, over time - the best and most accurate knowledge is accumulated into a sparkling whole; the wisdom of crowds at work. While this doesn't tend to work so well for contentious items - such as present day politics - or soft fields where truth is less important than oratory, the scientific community has gardened its sections of Wikipedia well.
The healthy life extension community should do the same. Many people will use Wikipedia to read up on present day efforts to extend the healthy human life span, or to understand the science and biotechnology that will shape our future longevity. All it takes is a little effort from each of us to keep things truthful, accurate, up to date and up to scratch - so make that effort the next time you're clicking through to Wikipedia. See something wrong? Correct it. Lacking a reference you know of? Add it. Missing an entry you'd like to see? Take a few minutes to start a stub article.
Wikipedia is a widely used resource; it greatly helps our cause to have it record the present state of our community and research towards healthy life extension technology.
Technorati tags: activism, life extension, Wikipedia
|
|
|
|
|
I stumbled upon an article the other day that manages to be quite right and quite wrong about the future of your life, insofar as finance and health go:
"As the first wave of America's 77 million baby boomers head into retirement this year, it becomes more critical for Americans to seriously evaluate how they will maintain their lifestyles as we live well into our 80s, 90s and beyond," said Stinson, president of Genworth's long-term care insurance business. "It's good news that the typical steep gains in nursing home costs have moderated this year. But the fact remains that most American households remain unprotected from the costly health challenges that come with greater longevity."
The poll also revealed most individuals recognized the need to prepare for the cost of long-term care, but were largely unprepared.
Many Americans surveyed also wrongly believed they had insurance protection, felt that their savings would be adequate to cover long-term care costs, and incorrectly believed that Medicare would cover long-term care costs.
The article is written assuming no change - all too common a fallacy these days, sadly - and that the world will proceed forward with the medical technology of the year 2006, or at least nothing much more advanced than that. Nothing could be further from the truth; even the least optimistic amongst scientists and realists are looking to large gains in healthy life span and ever less disability amongst the elderly in the years ahead.
Still, you must save and invest, or die. Harsh, but true. You will not be saving for nursing homes, however, or other equally unappetizing twilight scenarios of decay and suffering. Rather, you will be saving to afford the first and second generations of working anti-aging medicine; therapies and technologies capable of repairing age-related damage and extending your healthy life span. These will not be cheap at first, but even modest savings can net very large gains over a lifetime of diversified investment. You will need those funds. Folk have a way of believing that governments can create something from nothing, but governments are not magical entities capable of flouting basic economic truths. You shouldn't count on other people's taxes funding your healthy life extension - that way is the way to death and poverty for all. There is no free lunch, and certainly no free medicine; if you want to live healthily for longer, you will have to make sensible decisions now and work for it.
If you are forward-looking enough to support healthy life extension - in effect to make a better life for the you that will exist decades from now - then you are forward-looking enough to invest in ensuring that the future is as you would like it to be. A part of that is saving for yourself, but it is also vital to help fund present day efforts aimed at ensuring that healthy life extension technologies are developed. How you decide on that split is up to you; you will need to arrive in the future as a financially secure individual, but it doesn't matter how financially secure you are if working anti-aging therapies were not developed in time.
Technorati tags: libertarian, life extension, personal finance
|
|
|
|
|
The economic case for curing aging is a part of the general utilitarian case for aggressive investment of time, attention and capital into healthy life extension - minimizing suffering and death makes things better all round. It's something of a sad statement on the world in which we live in that there is any debate on this truth as an axiom of progress.
Here we have two posts from Anders Sandberg, reflecting on the Longevity Dividend proposal and some thoughts on the clash of gerontology paradigms at the Tomorrow's People event:
Ageing is after all a root cause for many expensive chronic diseases like cancer, stroke, dementias, arthritis, heart disease, osteoporosis and diabetes. Reducing ageing even slightly would reduce them significantly. In general it is better to go for underlying causes of illness than symptoms, as demonstrated by how the discovery of Helicobacter pylori enabled turning chronic and expensive ulcers into something treatable and rare. In fact, increasing lifespan by seven years would be a far greater gain than even totally eliminating cancer or heart disease. Beyond the medical savings longer lives also mean more productive work, more consumption and more human value – a larger economy. Many of the demographic pressures would be lessened, producing further multiplicative effects.
...
The basic idea is that life extension isn't just individually good, but also causes huge economic benefits - benefits likely to outweigh any costs caused by people living longer. Sure, we have to rewamp pension systems and construct a new concept of the path of life, but that is challenges far preferable to the enormous amount of suffering caused by ageing. If we could fix mortality to save the 100,000 dead each day it would be great, but even a modest gain in healthy life expectancy has a big leverage.
It was interesting to see the high noon confrontation between [Aubrey de Grey] and some of the authors of the paper mentioned above at last week's conference. On one end of the street the lone gunslinger Aubrey the Beard, on the other side the fearsome biogerontologist brothers. Of course, the real shootout has not yet started, this was just a few warning shots getting the bystanders to stand back. Much of the disagreement was due to the different conceptual approaches (engineering project vs. scientific study). But whoever is left standing afterwards, the idea that ageing is not immutable is going to prevail.
Which is a very good thing; moving healthy life extension science and debate on from "what is this" and "why do it at all" into struggles over implementation, approach and degree should be regarded as a major achievement. Once conservatives in the field traverse the hump of acknowledging that extending the healthy human life span is plausible and desirable, a defense of moderation is going to be increasingly hard to pull off in the face of ethical and scientific justifications for far more than a few years here and a few years there.
So bring on the heated debate over how scientists should proceed to enable us to live longer, healthier lives - the more people fired up and ready to get out there and prove their points, the better.
Technorati tags: life extension
|
|
|
|
|
David Chambers, one of the upstanding Methuselah Foundation folk doing good work behind the scenes, attended the Tomorrow's People event earlier this month. He had the following comments:
A few notes:
It was an interesting few days, and the conference attracted an impressive roster of the "Great and the Good", but I found the whole thing a bit perplexing. My 2c: Europeans don't look forward to a better future - but rather a managed version of the present. There's a distrust of revolutionary ideas, and the usual ritual genuflection towards equal opportunities, both societal and international. In such a conservative environment there's no place for transhuman optimism. And quite a lot of noodling on about pensions crises.
The session "Longer" clearly attracted the most interest. Speakers were [Aubrey de Grey], and three others: Kirkwood, Miller and Oshlansky. Kirkwood was urbanely dismissive of SENS and Miller displayed undisguised animus (which did him no favours). But Oshlansky unveiled his plan for US$3Bn p.a. federal research funding on aging, with the target of shifting the debilitation and death curve to the right by seven years. In the face of audience scepticism he was confident of success, suggesting that things may be progressing behind the scenes.
The magnitude of [de Grey]'s achievement really came home to me. In just a few years, and without any institutional backing, he has earned himself a seat on the sofa alongside these scientific luminaries.
While Euros and Americans might have their various hang-ups about the ethics and implications of the new biology, China doesn't. Pei Xuetao, of the Beijing Institute of Transfusion Medicine, made it very clear that China is open for business.
Miller has written an interesting paper identifying the obstacles to life extension research. He suggests that the political/scientific obstacle split is 85/15.
Miller is an interesting character; clearly very anti-SENS - as illustrated in a recent BBC article on this same event - but equally quite pro-healthy life extension insofar as he sees the realm of the possible. You can see that side in a Longevity Meme article excerpted from the Genomics Age, in his support of the Longevity Dividend proposal, and in the paper that David Chambers points out above.
So it is that debate within the gerontology community and related areas of biomedical research has progressed into the realm of "how much, how soon, how" - factions are forming and making their cases. That working technologies capable of extending the healthy human life span will come into being is a foregone conclusion, and that's a big improvement over past decades.
Technorati tags: gerontology, life extension
|
|
|
|
|
I gave a nod of thanks to the first 87 members of The Three Hundred in the latest Longevity Meme Newsletter:
Eighty-seven people have so far chosen to join The Three Hundred, generous supporters of the Methuselah Foundation and mostly folk of quite modest means. As taxes come and go in the US again, I think it's worth pointing out that The Three Hundred help to keep the foundation within the arcane boundaries of 501(c)3 nonprofit status as the larger donations mount.
While we all have our varying opinions on taxes and regulation - and I'm sure you know mine by now - I think that any excuse is a good excuse to point out just how much the Three Hundred are contributing to the future of meaningful anti-aging research and healthy life extension advocacy. I strongly suggest that you consider joining: where else can you leverage so much positive change for the future of health and longevity from a couple of dollars a day?
MPrize supporter Eric Boyd emailed me today with a positive step forward:
I have been trying to get up my dedication to join The 300, but it's a lot of money. I gave a little last year. In order to motivate/bind myself to join The 300 I have created a pledge:
http://www.pledgebank.com/Mprize300
With promotion on your blog I am sure that we can acheive this pledge. Help me cure aging!
I confess that I have not been following the development of Web 2.0-style philanthropic and nonprofit tools like PledgeBank as closely as I should, but this is an excellent utilization. A pledge of support for the MPrize for anti-aging research is exactly the sort of thing these services can help to enable.
So, you there in the audience, the folk who have been thinking about stepping up to make a real difference to the future of health and longevity - how about proving Eric right?
I will become a member of "The 300" at Mprize.org but only if 20 other people will too.
...
The 300 is a group of people supporting an anti-aging prize fund. Each member donates $1000/year to the prize. If 20 people signed up, that would add half a million dollars to the prize over the next 25 years, enough to make the prize significantly more attractive to researchers. Join me and help us cure aging!
$1,000 per year is a cup of coffee a day - many people of modest means lose more than that to careless finance or candy. These early years, in which advocacy is just as important as science, are a unique opportunity to leverage small amounts of money into world-changing progress. You can invest tens or hundreds of thousands of dollars over a lifetime of work, giving you comparatively good health and medical care in old age - but all that will come to naught if you haven't also invested in ensuring a future that includes working healthy life extension technologies. Suffering, aging and dying with a large 401k is still suffering, aging and dying; wealth cannot buy medical sevices that failed to come into being for lack of support.
Advocacy by organizations like the Methuselah Foundation and associated groups has had a large effect in just the past few years. You don't have to look back very far to see that a few advocates - with a few dollars, donated by people just like you and I - have engineered a sea change in the way the media and the scientific mainstream view and talk about healthy life extension.
You can help make this process even faster and more effective: sign Eric's pledge and join The Three Hundred.
Technorati tags: advocacy, activism, life extension
|
|
|
|
|
The death of a very long-lived tortoise prompted thoughts on aging and immortality in the animal kingdom over at the Speculist:
We humans are, for now, the practical distinction between nature and evolution. Evolution doesn't "care" how long any individual creature lives - as long as enough members of the species live long enough to spawn the next generation. Senescence is the product of evolutionary neglect - a lack of evolutionary pressure to live longer - not part of some grand design to clear the way for future generations.
But through evolution nature produced a species that both cares about life span, and has the potential to do something about it. Senescence could not be eliminated with evolution alone. A couple more informational epochs had to come along.
But conquering senescence is only natural.
This is a sentiment that I agree with - people who argue that the fight to cure aging is "unnatural" have it all exactly backwards. Nothing is more natural than for we humans to challenge, reverse-engineer and overcome our limitations in search of a better (and longer) life.
But back to animals and aging. A somewhat better synopsis of the evolutionary explanations of aging and its oddities between species was penned by Leonid Gavrilov and Natalia Gavrilova:
The evolutionary theory of aging may be considered as part of a more general life history theory, which tries to explain how evolution designs organisms to achieve reproductive success (i.e., avoid extinction). Life history theory is based on mathematical methods of optimization models with specific biological constraints. Among the questions posed and answered by life history theory are. Why are organisms small or large? Why do they mature early or late? Why do they have few or many offspring? Why do they have a short or a long life? Why must they grow old and die?
The latter two questions represent the entire scientific agenda of the evolutionary theory of aging. It could be said, therefore, that the evolutionary theory of aging is a subset of the life history theory.
Another worthy summary article for the layman can be found at Joao Pedro de Magalhaes' website.
A perhaps more striking, if overly simplistic, explanation for the existence of aging was given by Jaque Cousteau - no immortality because change is the lowest common denominator, and immortality in a species that cannot radically change itself spells extinction. It will ultimately find itself doomed by environmental changes, if not by evolutionary competition.
This doesn't preclude the possibility of an evolving clade of species with the necessary biochemistry for physical immortality; individual animals just won't have the chance to make much use of it. The Ageless Animals website provides an interesting view of outliers in the evolutionary processes that determine aging.
From where we sit, at the dawn of the biotech era, it is encouraging for our own prospects that species such as tortoises (and some whales) are capable of such extreme longevity. They aren't that different from us in the grand scheme of things, which would suggest that radical life extension via advanced biochemical and genetic manipulation - a large step beyond the present tinkering with metabolism - is a viable strategy for research in the decades ahead.
Technorati tags: biotechnology, immortality, life extension
|
|
|
|
|
Via Betterhumans, a fairly compact summary of one of the lessons that supporters of cryonics should learn from recent events in France:
RAYMOND MARTINOT and his wife have just had their 20-year slumber in a cryogenic freezer brought to a fiery end. Their son discovered that they had not been preserved at the temperature needed for the planned resuscitation in 2050. Regretfully, he had to have them cremated.
What is shocking about this story is not that a French couple were kept frozen in a basement by their son; nor the couple's belief that by 2050 they would live again. What is shocking is that the French Government was not going to let them try. A court order had already been obtained for the Martinots' cremation before the freezer failure. In France a corpse must be buried, cremated or formally donated to science.
...
What business is it of the State to dictate how to dispose of, or preserve, the body of a loved one? None.
...
A State that interferes in this delicate and private area exposes its cultural and religious bias - a dangerous thing in the modern, multicultural world. A State that denies the right to try cryogenic preservation stifles scientific investigation. A State that insists on only limited options for the dead inhibits creativity and invention. A State that dictates how best the dead may lie assumes a worryingly paternal position towards its citizens.
To discover the French Government telling its people what is right for them even after they are dead is no surprise. But one might hope things would be better in the UK. They are not.
Nor are they much better anywhere else. Even the US - home to Alcor and the Cryonics Institute, and once upon a time a culture with some very definitive ideas about freedom and the state - ensuring that regulations and government employees don't interfere in your preservation is a matter of some effort and luck. I blame the slow failing of property rights for all this, as for many other things. If you are held from determining the manner and timing of your own death (say, so as to ensure a good cryonic suspension with least damage to your brain), if you are held from determining the fate of what should be your first and most important possession - your body - than how, exactly, are you free?
The other lessons to take away from this are primarily economic in nature, some of which I've previously addressed, with the help of commenters. Cryonics provision is not something you can go at alone and hope to succeed - the odds are dicey enough already for the mainstream organizations. Quite aside from the complexities of performing a suspension - and leaving aside any debate over the capabilities of future technology and whether suspension methodology matters so long as the temperature is kept low enough - this is a high quality of service operation. You can't afford mistakes, and that immediately qualifies cryonics as a venture for process, formal organization, and a professional manner of doing business. No one person working alone can succeed in the long term, no matter how dedicated or diligent.
Technorati tags: cryonics, libertarian
|
|
|
|
|
The articles section of the Longevity Meme has been languishing of late, largely as a result of my time sliding away elsewhere. These fine essays - generously donated by the authors - continue to provide a good introduction to aspects of healthy life extension and its culture. There is always room for improvement and expansion, however, and the times keep moving on even as an essay remains static.
I have no desire to be all-encompassing - nor necessarily to get into the business of putting out articles on a regular basis - but I certainly haven't covered a broad range in terms of providing introductory material for newcomers. I hope it isn't the case that there is nothing more to say in the healthy life extension community's 101 class; that would be a disappointment.
So: suggestions are sought. Do you know of good essays penned in the past few years that have aged well and should be included? Are there glaring gaps in the topics covered? Please do let me know.
|
|
|
|
|
I don't normally give much time to research into regenerative therapies for non-age-related conditions, but it's worth glancing over the fence every so often - it helps in obtaining a feel for how fast medical science as a whole is moving. Here are a couple of recent items:
Scientists Hold Out Hope for Diabetes Cure:
Three years ago, scientists announced a new treatment had cured diabetes -- in mice. But researchers reporting in the March 24 issue of Science say three separate attempts to replicate that pioneering study have proven only partially successful. The results, while not stellar, still leave the cup of hope at least half-full for people with diabetes, experts say.
In fact, Dr. Denise L. Faustman, the scientist who performed the first study, contends the cup is still "100 percent full, because the new studies confirm that it is possible to stop the process by which the immune system mistakenly destroys insulin-producing islet cells." Islet cells reside in the pancreas, but are destroyed in the type 1 form of diabetes.
...
Type 1 diabetes generally appears early in life and is much more difficult to treat than obesity-associated type 2 diabetes, in which the body's insulin production gradually declines.
...
Meanwhile, she said, "We are actually elated by these studies. For 20 years, the hope has been that humans can regenerate insulin-producing cells. When we began this work we were not even allowed to use the word 'regeneration' in our papers. By 2003, we were able to use the word.
Cell therapy slows progression of an inherited neurological disease:
The new study, published in the March 22 issue of The Journal of Neuroscience, may have implications for developing new therapies for metachromatic leukodystrophy, or MLD, a fatal, relatively rare inherited disorder that in humans usually begins early in life. In the disease, the fatty substance sulfatide accumulates in the brain due to the lack of an enzyme and causes loss of the white matter or myelin protecting nerve fibers. Without myelin, nerves cannot conduct impulses to and from other areas of the body, resulting in symptoms including convulsions, seizures, personality changes, spasticity, progressive dementia, motor disturbances progressing to paralysis, and blindness. There is no cure; the only current treatment is a bone marrow transplant.
Ernesto Bongarzone, PhD, and his colleagues at the San Raffaele Scientific Institute in Milan, Italy, transplanted cells that produce myelin into the brains of newborn MLD mice. The researchers found that the transplanted myelin-producing cells survived in the mice brains and successfully moved to regions of the brain where they could aid in producing myelin. The transplanted cells also helped lead to production of healthy myelin and improved motor coordination.
Progress may seem slow at times, but researchers have come a long way in recent years. What happens in the laboratory today would have been - and sometimes was - science fiction back in the 80s.
Technorati tags: regenerative medicine
|
|
|
|
|
I will direct your attention to a press release on a non-cryonics use for vitrification:
Ice-free cryopreservation, or vitrification, methods for storing tissue engineered blood vessels have clear advantages over conventional freezing techniques and can accelerate the development and clinical availability of this alternate source of vascular grafts for surgical bypass procedures, according to a report in the February 2006 issue (Volume 12, Number 2) issue of Tissue Engineering
...
Vitrification is an ice-free alternative to conventional cryopreservation techniques. Whereas freezing of tissue samples results in damaging ice formation within cells and in the surrounding extracellular matrix, vitrification cryopreserves tissues without ice crystal formation. In vitrification, a supercooled liquid cryoprotectant solidifies, converting to a glassy state rather than to ice.
The authors demonstrated negligible ice formation in the vitrified samples. Importantly, they reported that engineered blood vessel specimens cryopreserved using vitrification had viability similar to that of fresh tissue and had contractile capability nearly 83% of fresh blood vessels, compared to less contractility of less than 11% for frozen specimens. They concluded that vitrification is a feasible storage method for tissue engineered blood vessels, which are being developed as an alternative source of vascular grafts for use in coronary or peripheral bypass surgical procedures.
All of which, of course, Alcor researchers have been demonstrating for a while now - but Alcor, like the rest of the cryonics community, is an oftimes marginal, non-profit, volunteer-driven, philanthropy-dependent organization. This is not to demean the worthy work accomplished there, but it is not a recipe for growth and long-term stability.
It is my contention that the cryonics industry needs to generate viable for-profit businesses in related areas of medical technology in order to support growth and a transition to a professional workforce for cryonic suspension services. This is clearly a possible path for the future, and is - to me, at least - clearly the best path for the future of cryonics. If we accept that cryonics is an entirely rational, responsible and ethical response to the problem of age-related death in a world on the verge of working anti-aging medicine, then the best path forward is that which generates the infrastructure capable of providing cryonics services to as many as possible who are able to pay the modest price.
Technorati tags: cryonics
|
|
|
|
|
Stephen Gordon at the Speculist catches a healthy example of the Tithonus error at large in the well-linked portions of blogosphere:
Last week, after hearing a prediction of 1000-year life spans from Aubrey de Grey, Roger L. Simon expressed concern about the possibility of living too long.
112 years, say, of retirement doesn't sound exactly enthralling. That's a lot of checkers and parcheesi. One of the scientists interviewed in the article said people are living vigorous lives these days in their 70s. Ho-hum. What about in their 140s? Anybody for 120 and over tennis?
I can understand why Roger Simon wouldn't want extra drooling years. The typical response to this concern from life extension advocates is to point out that it's not just life extension, but healthy life extension that is the goal. Bill Quick commented:
Roger. the biggest problem in talking - and thinking - about news like this is shaking the three-score-and-ten mindset. The question is not "120 and over tennis," but, "tennis for 120 year olds who are physically only twenty years old?"
Advocacy is certainly a spectrum - it's quite possible to be supporting efforts to obtain large-scale funding for the Strategies for Engineered Negligible Senescence (SENS) with one hand, while trying to dispel widespread and elementary myths with the other. Still, one would hope that some progress can be made in banishing the Tithonus error to the past. If half the population no longer knee-jerks in opposition to healthy life extension based on a false conception of "older for longer" - well, that can't be a bad thing for the prospects of raising a broad platform of support for research, can it?
Gordon goes on to say this:
I suspect that life extension will come in three major stages (with many, many incremental advances moving us forward). Stage one life extension will slow aging, stage two will halt aging, and stage three will reverse aging - essentially allowing us, with maintenance, to stay whatever age we choose. I think most life extension advocates would agree with this outline.
I will note that this is only most likely because of the prevailing winds of politics within gerontology and major funding sources - they are backing a slowing of aging (such as by research into the mechanisms of calorie restriction or general advances in medical technology) where they back healthy life extension at all. However, I think that the scientists associated with SENS make a credible case for reversing aging - by repairing age-related cellular damage - as an easier, faster prospect. Ramping up the funding and cultural changes to support that point of view is going to take time, however, and most likely more time that it will take the mainstream to gain further significant funding for their work on metabolism and longevity.
Technorati tags: life extension
|
|
|
|
|
The past couple of weeks have seen a wave of articles on the "anti-aging" marketplace, with an emphasis on the use, abuse, risks and culture of human growth hormone. Frankly, it'd be nice to see it all go away in favor of a focus on the future of longevity research - but this is what you get when you have a geared-up anti-aging delivery infrastructure and no real, actual, working anti-aging medicine to be delivered.
The A4Ms of the world will no doubt be sterling allies once effective healthy life extension therapies have been developed - working technology will chase out snake oil, but that will be way past the point at which sterling allies will be needed. The real fight is here and now, in building the infrastructure and support for research and development.
But back to the growth hormone and an article typical of those of the past weeks. From where I stand, growth hormone therapies appear to be a legitimate old-school style therapy for some age-related and other conditions. As for most old-school medicine, it's a roll of the dice as to whether you'll benefit or suffer - no-one can say for sure what's really going on under the hood, or how your biochemistry will take it. Use is an educated risk assessment that people have to make for themselves - and caveat emptor is a very good rule of thumb when dealing with anything associated with the "anti-aging" marketplace. If you had to stick a pin in the map for anti-aging shyster central, human growth hormone would be it - a pity that the legitimate uses have been buried beneath a cartload of marketing.
Still, in a free society, you could stick whatever you liked into your body provided you were prepared to foot the bill for the consequences. Sadly, we do not live in a free society; insofar as medicine goes, we live in a highly regulated, paternalistic, socialist enclave. A commons has been created, and every potential tragedy leads to calls for further control and expansion rather than the much more sensible abolition of the commons. From the article:
Other uses are illegal, including to turn back the clock on aging. The FDA says it is investigating violations of the law — the Food, Drug and Cosmetic Act as amended in 1988 and 1990 — and has sent warning letters to companies selling HGH over the Internet for other uses.
University of Illinois-Chicago epidemiologist Jay Olshansky, who co-authored a paper published last year in the Journal of the American Medical Association on legal issues surrounding HGH, said anti-aging doctors were surprised to learn they were on shaky legal ground.
They now are changing tactics by redefining growth hormone deficiency and making questionable diagnoses of their patients, Olshansky said.
"They've been administering growth hormone as an anti-aging intervention for a long time. They haven't been hiding it at all," Olshansky said. "Now they're trying to redefine it as a treatment for growth hormone deficiency."
Most prescriptions for HGH should go to children, according to Dr. Thomas Perls of Boston Medical Center, but 74 percent in 2004 went to people age 20 and older.
"In my opinion, that suggests a large amount of illegal distribution," said Perls, a co-author with Olshansky of the JAMA paper and director of a project that studies people who live to age 100.
Olshansky and others have been sparring with the "anti-aging" marketplace for a while now, and over quite justifiable complaints, but I see resorting to "it's illegal" as lowering the bar for everyone. If you're going to attack, attack on the science - there's certainly enough to be going with there. FDA-defined legality, and in fact any defined legality of substances, is the tip of a large, cruel joke that wouldn't exist in a culture worth living in. Supporting these policies damages medical progress - and thus health and longevity - for everyone.
In summary: growth hormone therapies for general use are a big red lever on the slot machine, calorie restriction seems a far better bet, shysters are everywhere, and this is all a damaging distraction from the development of far better options for the future - but if you own the slot machine and are prepared to pay for the consequences, the decision to pull or wait, listen to shysters or not, should be all yours.
Technorati tags: anti-aging, libertarian
|
|
|
|
|
Two unrelated items of interest today. Firstly, one of the Immortality Institute members dug up a 1972 Jacques Cousteau commentary on physical immortality in the context of evolution:
Imagine an immortal animal. ... Has evolution ever produced such a prepossessing creature? Theoretically it should be possible for the various components of the endocrine system of an animal so efficiently to collaborate that physical obsolescence is simply banished from its life program. We know of certain plants--for example, lichens and the bristlecone pines of California's Inyo Forest--that live many thousands of years, near enough to immortality so far as animal lifespans are concerned. But the oldest animal of which there is a record seems to be a tortoise that managed to struggle through 150 years (plus, perhaps, another 25 years or so)--not all that much older than many old men.
Paradoxically, if immortality has ever been attained, it has quickly been eliminated, simply because immortality cannot survive. An immortal animal would be a dead animal--the representative of a vanished species. As we saw in the first volume of this series, Oasis in Space, as least four times in the past 600 million years the reef communities around the world have all been all but obliterated by upheavals in the environment still not completely understood. Skeletons of palm trees have been discovered in Antarctica. At one time there were meadowlands on that continent, now under hundreds of feet of ice, not unlike the plains of the American West. Faced with this dimension of drastic environmental transformation any immortal animal would be helpless. His ideal adjustment to the old environment spells certain extinction in the new. Locked into this "perfection," he cannot adjust. Immortal or not, he must die.
This is somewhat of a reductio ad absurbdum in demonstration of ideas that are commonly held today by evolutionary biologists. A nice find, and a reminder that the roots of all present ideas run deep.
Meanwhile, and switching topic, this New York Times article is a good illustration of the damage done by the cancerous encroachment of intellectual property:
Elevated homocysteine is linked to B-12 deficiency, so doctors should test homocysteine levels to see whether the patient needs vitamins.
ACTUALLY, I can't make that last statement. A corporation has patented that fact, and demands a royalty for its use. Anyone who makes the fact public and encourages doctors to test for the condition and treat it can be sued for royalty fees. Any doctor who reads a patient's test results and even thinks of vitamin deficiency infringes the patent. A federal circuit court held that mere thinking violates the patent.
...
For example, the human genome exists in every one of us, and is therefore our shared heritage and an undoubted fact of nature. Nevertheless 20 percent of the genome is now privately owned. The gene for diabetes is owned, and its owner has something to say about any research you do, and what it will cost you. The entire genome of the hepatitis C virus is owned by a biotech company. Royalty costs now influence the direction of research in basic diseases, and often even the testing for diseases. Such barriers to medical testing and research are not in the public interest. Do you want to be told by your doctor, "Oh, nobody studies your disease any more because the owner of the gene/enzyme/correlation has made it too expensive to do research?"
If you accept that open competition under the rule of law and strong traditional property rights is the best way to harness the baser nature of humanity to produce progress, then it quickly becomes obvious that patents - and indeed any form of intellectual property - are a very bad thing indeed. Ideas, designs and data are fundamentally different from raw physical materials. Like so many other forms of governmental interference in a free market, the spread of patents provides short term enrichment for those who can buy influence, but at the dreadful cost of slowing progress for all of us.
There are any number of business models for medical science and provision - as for every marketplace - that do not require intellectual property. Look at any industry comparatively lacking in intellectual property restrictions and you'll see high levels of dynamism, creativity and competition. Stifle these things and you stifle progress.
You can be as rich as you like, but it isn't going to help you all that much if your wealth came in the form of a tax that discouraged basic scientific research on the condition that will kill you. You can't buy what doesn't exist - and you certainly can't buy what fails to exist because of your actions. Hopefully, I do not need to remind people that a day lost across the board in medical research costs 100,000 lives and another day of terrible suffering for tens of millions.
Technorati tags: aging, immortality, intellectual property, libertarian, patents
|
|
|
|
|
It's been a good three years or so since I redesigned the Longevity Meme, and Fight Aging! has operated in its present format for two years now. That last redesign was prompted as much by changes in focus and actitivies as a desire to update the look and feel; that functional pressure for an update is growing once more.
The aims of the Longevity Meme and Fight Aging! have drifted somewhat over the years, and are usually at least a little out of sync with my own views on what would be the best foot forward at any given time. The high level goals remain much the same as they were at the outset, as expressed in the Longevity Meme mission statement:
- Educating the general public of:
- Benefits and possibilities resulting from the ongoing and future development and acceptance of healthy life extension technologies;
- Ways in which ordinary individuals can make meaningful contributions to the development and acceptance of healthy life extension technologies;
- Existing healthy life extension technologies, techniques and lifestyles.
Supporting the creation, publication, promotion and distribution of educational and promotional material about healthy life extension and related topics;
Creating, assisting and supporting healthy life extension communities, organizations and events that share objectives and purposes with the Longevity Meme;
Generating positive coverage of healthy life extension issues in all forms of media, with a particular emphasis on the forms of media that reach the greatest proportion of the general public;
Advocating the continuing and future development of healthy life extension technologies
My hierarchy of importance and details of implementation have changed with the times, however - last in that list above is presently the foremost of my concerns, for example. Also, I no longer feel much of a need to promote present day healthy life extension methodologies; other people are doing a sterling job for the few that exist, such as calorie restriction.
Beyond these points, communication processes, technologies and - most importantly - culture have shifted quite dramatically in the past few years, and continue to move at a fast pace. If the objective is to effectively deliver a message to as many people as possible as efficiently as possible, you must move with the times ... if that is even still the primary objective. Growth has been pretty flat for a while now, which means it's time to evaluate what I'm up to - and what I think "growth" means, for that matter.
Planning for a redesign moves fairly slowly in this part of the world; the purpose of this post is to let folk know that I'm open to comments and suggestions. My time and resources are limited, and so I would like to be putting them to use in ways that are efficient, effective, and neither duplicative nor wasteful. If you have constructive thoughts on the matter, let me know.
|
|
|
|
|
Via the IEET blog, we have the not too inspiring results of a Zogby poll commissioned by Future Brief:
The following questions were submitted by Future Brief readers. The poll itself, given to a group of more than 13,400 likely voters, was conducted by Zogby International, an opinion research firm, on January 27-30, 2006.
...
QUESTION: Which of the following would you most like to see accomplished through the development of emerging technologies?
RESULTS:*
- An end to world hunger: 18.2%
- An end to disease: 20.5%
- Extended life-span: 5.4%
- Exploration of the universe: 4.7%
- An end to fossil fuels: 45.6%
- None/Not sure: 5.6%
I can only imagine the sort of survey setup that results in half the respondants prioritizing new energy production technologies over ending disease...or am I being too charitable to these folk given the zeitgeist of the moment and the casual nature of most polling interactions?
The entrepreneur in me knows that you can build a billion-dollar business - or change the world, hold a revolution, and so forth - with only 5.4% of the population as your supporters or target audience, but still. 5.4%? I think we can - must, and will - do much better than that.
Technorati tags: life extension
|
|
|
|
|
It had slipped my mind that the last Life Extension Magazine included a pop-sci article on a range of regenerative medicine research. It's a publication in which reading between the ads and junk is something of an art form - as for all the successful old school pro-healthy life extension businesses - but at least it all ends up online for folks to pick over at greater leisure:
Researchers at the Wistar Institute in Philadelphia, PA, are studying a unique strain of mouse that can heal wounds by regeneration. After a hole is pierced in the mouse's ear (a typical laboratory identification procedure), it closes with no evidence that a hole was ever present. These animals, known as Murphy/Roths/Large mice, or MRL mice, are so named to denote the two scientists who originally bred them, as well as their unusually large size. MRL mice are genetically unique, and scientists are researching them to elucidate the genetics of regeneration, hoping to gather information that can be used to help humans.
When the Wistar scientists induced heart injury in both MRL mice and typical mice, they found that the MRL mouse heart returned to normal, whereas the typical mouse heart was scarred. Human hearts scar following injury from heart attack, and the scarring response contributes to chronic heart disease and death. The healing response in the MRL mouse, however, differed greatly from that of the typical mouse. The MRL mouse displayed early movement of cardiomyocytes into the wound site, and DNA synthesis and proliferation of these cells. The MRL mouse heart also demonstrated better revascularization (restoration of blood supply) at the site of injury, which is necessary to help cells thrive and avoid death. According to the scientists, the MRL mouse studies demonstrate that "mammalian hearts have significant capacity to regenerate."
...
Millions of dollars are spent each year to develop tissue engineering products and procedures. In fact, some engineered tissues have already been approved by the FDA. One of the first tissues to be engineered and used clinically is bone. Engineered bones, cartilage, tendons, and ligaments may benefit people who suffer from bones that will not fuse, defective tendons, or arthritic joints, as well as those who need dental implants (which require strong bone tissue). These regenerated tissues will one day eliminate the need for standard therapy, which includes stainless steel, cobalt chrome, and bone grafting.
Scientists are also developing engineered skin, which will help treat massive burns, chronic problem wounds that are difficult to heal (common in people with diabetes), and vitiligo (a disease of discolored skin). Although heart valves have been engineered, the valves failed when they were implanted. A whole bladder has been engineered and transplanted in a dog. The bladder appeared to be normal and demonstrated normal function. An engineered bladder has not been evaluated in humans. Nearly every body tissue is being engineered for future applications in medicine.
There's more on MRL mice back in the Fight Aging! archives and at the Longevity Meme - I expect promising medical science to materialize from that discovery in the years ahead.
Technorati tags: regenerative medicine, tissue engineering
|
|
|
|
|
The Tomorrow's People event is presently underway; the more interesting sessions for those interested in healthy life extension took place today. Webcasts in RealPlayer format can be found here:
- "Longer?" with Sarah Harper, Tom Kirkwood, Aubrey de Grey, Jay Olshansky, Richard Miller and Paul Hodge
- "Stronger?" with Bill Sharpe, Ellen Heber-Katz, Kevin Warwick, Xuetao Pei, Toshio Fukuda and Zhanfeng Cui
UPDATE: A better collection of links to video and audio streams, plus powerpoint presentations, can be found in the Immortality Institute discussion thread for this event.
Hopefully you folks have better luck than I in getting these streams to work. For the technologically challenged, there are discussion boards and PDF-format updates:
Aubrey De Grey believes that people can live much longer through a different approach - rejuvenation. "If we start repairing the damage caused by ageing early enough, we stand a good chance of reversing the devastating effects of ageing for good." For De Grey it follows that partial and periodic repair yields more ageing delay than partial prevention, thus it's more effective. But other scientists worry that such – in their view – unwarranted optimism will put off policymakers and the public.
Richard Miller fears that prospects of sufficient funding towards gerontology have been eclipsed largely by misrepresentation and lack of public trust. "We are essentially dealing with the syndrome of gerontologiphobia. That means fear of what might anti-ageing drugs do to society." Even more so, he urged us to think about the way gerontologists are portrayed by the public. "Most people think that gerontologists are crackpots and who wants to hang out with that sort of person?"
Let's be clear here: you don't engineer great strides in technological progress by watering down the message and intent so as to stay within any existing comfort zone. The way forward is to work on extending that comfort zone through education, awareness and outreach, while gathering the support of as many people as possible who are already in your camp. We have made great strides in extending the comfort zone in the past few years; articles that would have been unthinkable in 2000 appear in the mainstream press on a regular basis.
Radical life extension is a plausible medical engineering project - not easy, not cheap, but plausible. Moving away from that truth will not make our lives longer and healthier any faster; rather it will just excuse slower, less ambitious programs, and otherwise avoidable aging and death. That's certainly not the plan I have in mind for the next few decades.
Technorati tag: advocacy, life extension
|
|
|
|
|
I'm noticing, now that the discussion of healthy life extension research is spreading, that "life extension" - as a label for the sort of results we'd like from medical science - is a pretty thin brand. Run a Google news search or blog search for the term every few days for a month or so and count the number of distinct talking heads; there aren't that many. In the past year, writers in the mainstream press have settled on any number of other terms to describe the lengthening of the healthy human life span; "life extension" has little mindshare out beyond the core community of supporters.
This means that it's pure speculation as to the banners under which the future of meaningful anti-aging research will be conducted. "Anti-aging" would be the obvious contender if not for all the history and baggage it drags with it. "Life extension" is all but falling by the wayside in the wider discussion. As an example, take a look at the Longevity Dividend article in The Scientist - each term is mentioned once, and only where it couldn't be avoided.
So what shall the brand of the future be? Speculation is encouraged.
Technorati tags: life extension
|
|
|
|
|
As a general rule, I don't feel it necessary to include the Standard Libertarian Disclaimer in everything I write. For sundry well-thought-out reasons, I'm not a supporter of government funding, and barely a supporter of the very existence of government. Freedom means far more than living in a representative democracy of eroding rights, strong property rights are necessary for progress, and the rule of law is vital. Incentives matter, and economic ignorance is the doom of cultures.
Most of the ills that beset the world can be traced back to our distressing tendency to build and support governments that destroy the roots of progress, wealth and freedom - and the remaining ills, such as degenerative aging, could be solved through sufficiently rapid advances in technology. These rapid advances depend, of course, on progress, wealth and freedom.
Most regular readers will know by now that I am a generally pragmatic libertarian:
Western style democracies are about as far as you can get from a libertarian society and still have a place that's moderately pleasant, free and safe to live in - so long as you blend in and don't make enemies amongst the powerful. Many people believe that high tax rates and lack of freedom (due to a winner-takes-all majority rule system of government and the preponderance of unaccountable, unelected officials) are the necessary cost of personal safety in a modern civilization. The only high profile modern alternatives - dictatorships - are invariably very much worse places to live, after all. But it is simply not true that we need high taxes, large government, and unaccountable officials: there are better ways of doing things.
In any case, how does this little sidebar fit in with healthy life extension? The answer is that in a world of large government, in which a good 35% of all medical research funding is provided by government grants, you can't ignore the system. It is an open question as to whether public funding for medicine speeds the rate at which real anti-aging and healthy life extension therapies are made available more than other aspects of a large government slow things down. For example, it is well known and documented that high taxes have a devastating effect on the economic engine that powers growth, commercialization and advancing technology.
As an individual, you can't change the system on a useful timescale. People are making serious organized attempts to create more libertarian societies, but this has little direct bearing on the large scale advance of real anti-aging science over the next decade or two.
Hence, we come to pragmatism. Between the two biggest problems I see in life - a) that we are aging and will all suffer and die if nothing is done, and b) that society is far less free and honest than it could be - aging is clearly the problem to be dealt with first. There's a time limit attached to it, and I am very much a first things first type of person.
So I draw my lines in a pragmatic manner. At the moment, I support working within the system to the extent of protesting government restrictions on research (although a more libertarian postion would be that any such interaction with government has the undesirable effect of legitimizing the very system you oppose). I'm not a big fan of the California stem cell research ballot initiative, but only because I think that too much (big government restriction and interference) bad is coming with the (research dollars) good on that one. Private projects like the Methuselah Mouse Prize, or any number of foundations and research groups are just fine in my book.
You folks should draw your lines where you please. I'm not a jealous libertarian, like some I could mention, and I'm certainly not telling you what to do. If you are comfortable with living in a Western democracy, more power to you; in a truly plural society you would be able to do so without forcing me to do so to as well. But we don't yet have such a thing, and probably won't until new frontiers - space, virtual nations, ocean living, floating cities in the upper atmosphere, and so forth - are opened up through advancing technology.
I'd be willing to take a first things first, utilitiarian approach to government funding if I thought it would lead to a net gain in longevity over the alternatives - better to be alive to build a libertarian society in the future, as opposed to dead, buried and no help at all. Supporting government funding means supporting massive waste and inefficiency in the use of those funds, however. It also means tacitly supporting vast damage to progress across the board; this is not good.
Why this little interlude? It seems that the absence of the Standard Libertarian Disclaimer in posts, critical and otherwise, and the last weekly Longevity Meme newsletter on the topic of the Longevity Dividend proposal caused a couple of folk to grumble about my endorsement of large-scale government funding. I can assure you that no such endorsement exists! My enthusiasm is related to the fact that the recalcitrant mainstream of gerontology has finally cracked, its core members coming out to endorse specific goals for healthy life extension in public. For any of us following matters - or pitching in to help - over the past few years, this is a terrific development and validation of our work.
As to the government funding side of the Longevity Dividend initiative - seeking $3 billion per year for defined goals in anti-aging science - well, these are mainstream scientists in the US. Did you really expect anything else to be their next step after the declaration of intent?
Technorati tags: libertarian, life extension
|
|
|
|
|
StumbleUpon (the best tool no-one talks about, so long as they keep the paid placement to a minimum) delivered me to a good defense of applying resources to healthy life extension:
It is slowly becoming more and more clear that we are approaching a revolution just as great as the Industrial Revolution once was, and maybe even more so - the Aging Revolution. As medicine and science keeps advancing, we are approaching an era where we'll have the technology to obsolete aging and age-related death. In short, medicine will be able to make us live as young and healthy for a lot longer, perhaps even forever. The view that we'll be able to achieve an eternal youth during our own lifetimes is endorsed by the SENS project, and even many of its vocal critics think that the healthy lifespan could be increased, though they don't think aging could be entirely prevented. In any case the general direction does seem to be clear - given sufficient funding, the ability to drastically increase our lifespan will soon be upon us.
...
However, one argument - one that sounds like it'd make perfect sense if you didn't stop to think about it too closely - pops up every now and then. "We could cure malaria and extreme poverty and [insert disease here] whenever we wanted to - isn't it more important to concentrate on that?"
Read the whole thing to see this argument taken apart and demolished - feel free to pitch in to the discussion taking place in the comments. Thoughtful folk who support rapid progress towards healthy life extension should certainly be encouraged.
I see this class of opposition to healthy life extension as a facet of general economic ignorance and the false quest for "equality" - the desire to build at the bottom by tearing down the top. Quite aside from the fact that you'd have to stamp out freedom to do it, thereby destroying all that is good in our culture, from a pure utilitiarian standpoint this process of equalizing by building up the bottom and tearing down the top never works. Look at the Soviet Union for the logical endpoint of serious attempts to structure a society this way - or to structure a society at all, for that matter.
Technorati tags: libertarian, life extension
|
|
|
|
|
Anders Sandberg - long-time contributer to the general verve of the transhumanist community and now a part of the Future of Humanity Institute - responded to a rather deary, dreadful pro-death-and-suffering column in the Financial Times with the following letter (via the IEET blog):
In his column "Why immortality would be a dead loss for humanity" (February 28) Richard Tomkins worries that a longer healthy lifespan would leave us in a boring, risk-averse society. Most evidence shows that the people who today reach high age tend to be interested in life and willing to do new things. It is unlikely that will change with better medicine except that more people will be healthy and vigorous. Longer lives might induce us to more long-range planning, but that is hardly a drawback.
Ageing and death deprives society of tremendous values and knowledge, while healthier lives provide society with increased experience, labour, consumers and producers. Longer lives would be a tremendous boon to economic growth. As shown in Measuring the Gains from Medical Research: An Economic Approach, the value of improvements in life expectancy is about as large as the value of all other consumption goods and services put together: the total value of the increased longevity that took place from 1970 to 1990 has been enormous, in the order of $2,800bn a year in the US. The sheer economic power of a more long-lived society might be a strong stimulus for adventure and growth, especially among the young who seek new niches rather than compete with their elders.
Even if successful anti-ageing would cause serious social problems, confound the religious, upset the current pattern of life (which is fairly recent, historically speaking) and cause more divorces, it might still be worth doing. Would these problems be so horrific that it is better to sacrifice more than 100,000 lives a day worldwide to avoid them? It seems unlikely.
As for life as a story with a beginning, middle and end, it is well worth remembering that there are short stories and epics. Would you rather be a Harlequin romance or Lord of the Rings?
If you like life and health, and I suspect that most of us do, more of both is a wonderful thing. We can hope that advocates for healthy life extension only have to repeat the stunningly obvious so many times before it sinks in - the ongoing toll of death and suffering is terrible, staggering, but we are entering an era in which we are within reach of preventing this horror. There is no need for self-protective justification of the inevitable any more; we should be moving towards working anti-aging medicine with the greatest haste possible.
Technorati tags: advocacy, life extension
|
|
|
|
|
We're far enough into the biotechnology revolution for longer-term studies - such as actuarial calculations, census-based demographic data, large-scale medical reporting reviews, and the like - to begin showing resulting trends in improving health and longevity:
The report, 65+ in the United States: 2005 [PDF], was commissioned by the National Institute on Aging (NIA), a component of the National Institutes of Health, to provide a picture of the health and socioeconomic status of the aging population. It highlights striking shifts in aging on a population scale
...
This report tells us that we have made a lot of progress in improving the health and well-being of older Americans, but there is much left to do.
...
The U.S. population age 65 and over is expected to double in size within the next 25 years. By 2030, almost 1-out-of-5 Americans - some 72 million people - will be 65 years or older. The age group 85 and older is now the fastest growing segment of the U.S. population.
...
The proportion with a disability fell significantly from 26.2 percent in 1982 to 19.7 percent in 1999.
Another mainstream media digest of the report:
What we're seeing nationwide is, yes, people are living longer, and they're healthier
...
In 1900, the average life expectancy for a newborn was 47.3 years; by 2003, it had reached 77.6 years. But people who turned 65 in 2000 could expect to live much longer, another 18 years.
This progress in lengthening our healthy life spans will continue provided that medical technology continues to be made more capable, reliable and less costly with each passing year - there are no necessary limits to active, healthy human life span beyond our lack of tools and knowledge to fix the accumulated damage. We are complex machines - better means of repair and a better owner's manual will lead to less damage, fewer system failures and longer healthy lives. A very good thing!
Some systems biologists see 10-20 year extensions of healthy life spans within two decades, resulting from general improvements in medical technology based on present trends - but we think it's possible to build a much better foundation for the effective treatment and repair of age-related cellular damage than that.
Technorati tags: aging, life extension, longevity
|
|
|
|
|
Not everyone is wholly enthused by the declaration of intent on modest healthy life extension and call for a repurposing of mainstream gerontology and aging research put forward by Olshansky, Perry, Miller and Butler.
Olshansky wants you to live an astounding 7 years longer!
Direct from the 'lack of vision' department comes S. Jay Olshanksky's latest offering to the great life extension debate.
...
But typical of Olshansky, his limited vision for the potentials of life extension is at the point of laughability. He once told me that it is his expectation to see life expectancy decrease this century rather than increase, citing such things as the spread of diseases.
Olshansky, professor of epidemiology and biostatistics at the University of Illinois, and go-to boy for the press when they need an anti-life extension sound-bite, argues that it is in society's best interest to work at alleviating the effects of aging. To this end he suggests that US congress invest $3 billion annually to life extension with the hopes of prolonging lives by a factor of -- drum roll please -- an astounding 7 years.
Yep, 7 years.
The bandwagon is open:
Now.. where have I heard this before? Oh yeah.. its just what Aubrey de Grey has been saying for YEARS!
...
The article however makes one significant and really quite dramatic error in putting forward the goal of fighting aging is to 'compress morbidity'. The "compression of morbidity", or the reduction of the number of years spent as a frail individual without significant extension of maximal lifespan is a non-starter and neither is it desirable. Why don't the authors simply say it like it is, that living as long as a person wants to live is the goal. The 'compression of morbidity' is a red-herring meant to assure people that they do not have to have some existential angst triggered by the fact that someday death may not come by involuntary means through aging at all.
As if to further distance themselves from any possible association with the idea of living indefinitely, "the target" of their proposed increased focus on intervention oriented aging is research is ..
...not the unrealistic pursuit of dramatic increases in life expectancy, let alone the kind of biological immortality best left to science fiction novels. Rather, we envision a goal that is realistically achievable: a modest deceleration in the rate of aging sufficient to delay all aging-related diseases and disorders by about seven years.
How disappointing it is to see the more than realistic proposals of SENS treated in such a off-hand and perjorative manner by people advocating healthy life-extension. It is even more disappointing to not even have Aubrey de Grey mentioned although it is virtually certain that without his sabre-rattling we would not be reading even this meager pronouncement. Granted these are the same individuals who have outright belittled and ridiculed the idea of living indefinitely, so I would expect no more. Seven years though.. ? How ambitious...
These are valid criticisms - that this proposal is late to the party, fails to acknowledge those who have been advocating similar approaches for some years, and touts a target for gains in healthy life span that is somewhat less than the actuaries and system biologists think will be attained in the next 10 to 20 years by present trends and research directions.
I am still enthused; these folks have taken the big step of adopting a public position on healthy life extension. It has been a long fight to get them to this point, all the way from their prior reluctance to engage on the topic at all. Olshansky, Perry, Miller and Butler and their supporters and organizations must now defend this position - and therefore debate the science - in public on an ongoing basis. Since their position is already somewhat indefensible in its moderation, and only going to get worse with time, I predict that it will shift to greater and more impressive healthy life extension as the leading edge of the research community pushes the limits of plausibility outwards. The dam has been broken, and bringing the obstinate old guard up to speed is now only going to get easier.
The Longevity Dividend proposal is primarily a political position - which should instantly explain most of its deficiencies to those who follow the way in which funding politics works. It's the first step in a long engagement with large-scale government funding sources (such as the National Institute on Aging) in an attempt to steer future funds into the sorts of moderate programs supported by its authors. That Miller, et al, are doing this at all illustrates, amongst many other things, a concern that future funding will dry up in favor of groups presently moving to advocate healthy life extension - such as those system biologists, or supporters of the Strategies for Engineered Negligible Senescence. Thus this faction of the mainstream is basically on board already; competition at work!
This all acts to build a better funding environment, supporting continued advocacy and fundraising efforts for research aimed at more impressive healthy life extension. The more scientists who go on the record in support of any degree of healthy life extension, the more condusive the overall environment becomes for leading edge work.
The Longevity Dividend proposal demonstrates that avoiding the trap of moderating our message brings results: it makes the mainstream get into gear and start to see things our way. Therefore, I say it's time to step up the support for radical life extension, the Strategies for Engineered Negligible Senescence, and an engineered cure for aging!
Technorati tags: advocacy, gerontology, life extension
|
|
|
|
|
While we're still in the wake of the Longevity Dividend and the implied redirection of mainstream gerontology, I should note that The Scientist gave the Methuselah Foundation's MPrize for anti-aging research a good mention:
Interested in getting in on some big cash prizes but don't have the sequencing capacity or rocketry experience to compete in the more well known X-prize competitions? If you're good with mice, all you might need is time. In putting together the March feature on aging by S. Jay Olshansky and colleagues we came across the Methuselah Mouse Prize or M-prize. Funded by private donors, the M-prize is brainchild of Aubrey de Grey, the Cambridge geneticist who contends that with proper maintenance (yet undiscovered), humans could live for hundreds or even thousands of years. The prize is awarded in two categories that have been variously named over the years but currently go by longevity and rejuvenation.
Have you given thought to the MPrize of late? There are no doubt dollars in your life that could be put to better use, encouraging scientists to develop healthy life extension technologies soon enough to benefit folk like you and I - a big long-term return on investment if ever there was one. The latest member of The Three Hundred joined just recently, generously contributing to the future of meaningful anti-aging research - how would you like to be the next in line?
What's it worth to you to live 150 healthy years? What's it worth to you to raise the average human lifespan to 150 years, just as a start? These are not idle questions! Membership of The Three Hundred is a meaningful but affordable commitment: $1,000 a year, by the end of each year, for 25 years. This amounts to $85 a month or $2.75 a day, the equivalent of a visit to Starbucks.
The Three Hundred is a classical concept, based on a battle that saved the future of Western Civilization: Thermopylae. In 480 B.C., 300 Spartan warriors fought against incredible odds to gain time for the rest of Greece to mobilize against the Persian hordes. Without the delaying action fought at the narrow pass of Thermopylae, the achievements of Greece and our culture as we know it would have been swept away.
The Methuselah Foundation is asking you to follow in the footsteps of this noble Three Hundred, not to risk your lives, but to provide some of your treasure so that we can all live ... and live ... and live. You will help to win time for the human species to beat back an enemy far more dangerous than the ancient Persians: the Grim Reaper himself.
The Three Hundred - a group strictly limited to 300 members - will live on in history, as the Three Hundred of Thermopylae are remembered even to this day. You can be one of them. The names of the 300 Spartans who fought at Thermopylae were engraved on a stone tablet in Sparta that was still legible seven centuries later. A momument stands to this day to pay homage to their sacrifice. In lending your name to this enterprise, you will be remembered for as long as the human race survives.
The MPrize is already proving its worth, as part of the advocacy that is leading modern gerontology out of its rut and into open support for healthy life extension research. We are at a real juncture in the history of medicine; success in advocacy today will lead to greatly extended healthy life spans and the defeat of age-related frailty in the decades ahead. There is so much more that can be done, and more hands make all the difference!
Technorati tags: activism, advocacy, life extension, medical research
|
|
|
|
|
The past few weeks of posts here at Fight Aging! have included discussions of strategies for large scale funding, avoiding moderation in pro-radical life extension advocacy, how to pitch a moderate healthy life extension message if you must take that path, and looking at the likely future of mainstream / moderate pro-healthy life extension engagement with existing funding sources.
In essence, scientific anti-aging advocacy of the past few years, within and without the research community, is bearing fruit. Scientists who have long supported healthy life extension research in private now feel the environment to be safe enough to speak out in public without risking status and funding. This is a huge step forward, as many in the scientific mainstream strongly support the legitimacy of research aimed directly at extending the healthy human life span. But if no-one stands up to say so, funding and legitimacy cannot be established - which is why it is such a big deal that we are now moving away from healthy life extension research as the instant death third rail of grantsmanship.
You'll find a glowing neon signpost of progress in this month's issue of the The Scientist ... which, funnily enough, has the phrase "fight aging" prominently placed on the cover. The cover article is authored by S. Jay Olshansky, Daniel Perry, Richard A. Miller, and Robert N. Butler, who collectively stand as core and representative of mainstream gerontology and aging research. These are folks who, as you may have noted in the past, are usually on the other side of a timescale or plausibility debate with biomedical gerontologist and radical life extension advocate Aubrey de Grey. Here, however, they are starting a campaign of engagement with existing funding structures intended to produce programs and resources for healthy life extension research:
Gerontology has grown beyond its historical and traditional image of disease management and palliative care for the old, to the scientific study of aging processes in humans and in other species-the latter is known as biogerontology. In recent decades biogerontologists have gained significant insight into the causes of aging. They've revolutionized our understanding of the biology of life and death. They've dispelled long-held misconceptions about aging and its effects, and offered for the first time a real scientific foundation for the feasibility of extending and improving life.
...
People already place a high value on both quality and length of life, which is why children are immunized against infectious diseases. In the same spirit, we suggest that a concerted effort to slow aging begin immediately - because it will save and extend lives, improve health, and create wealth.
...
The science of aging has the potential to produce what we refer to as a "Longevity Dividend" in the form of social, economic, and health bonuses both for individuals and entire populations-a dividend that would begin with generations currently alive and continue for all that follow.
We contend that conditions are ripe today for the aggressive pursuit of the Longevity Dividend by seeking the technical means to intervene in the biological processes of aging in our species, and by ensuring that the resulting interventions become widely available.
I'm very enthused by these signs of progress. This is not support for the Strategies for Engineered Negligible Senescence or similar full-on engineering, damage-control approaches, but it is a large departure from the position of public silence on healthy life extension. The sea change in public opinion and awareness brought on by advocacy is creeping up on us, and factions within the scientific community are adjusting the cut of their sails in expectation of funding. As Olshansky noted over at the Immortality Institute:
We are calling for a massive national and international effort to slow aging in humans under the premise that by doing so, humanity would reap a series of "Longevity Dividends" -- a gift to humanity from our generation to most current and all future generations. What is new here is the articulation of the "dividends" and the "target". I'll present this idea formally at the World Forum meeting in Oxford on the 15th of this month, but this is just the beginning of our effort to make this happen.
The mainstream is moving. Progress!
Technorati tags: advocacy, gerontology, life extension
|
|
|
|
|
It is pleasant to be presented with the prospect of a comparatively simple mechanism at the root of an extremely complex array of age-related medical conditions. Simpler roots to a range of complex biological failure mechanisms are what we would expect to find if approaches like the Strategies for Engineered Negligible Senescence are to be much more cost effective - and produce results more rapidly - than treating the end results of age-related cellular damage. While the complexity of failure modes should be greater than the complexity of multiple root causes, it's not always the case that knowledge of biochemical processes and the capabilities of modern biotechnology are up to sorting out all the loose ends and chains of causality. Yet.
In any case, various news outlets are reporting on the possibility of comparatively simple mechanisms at the root of most age-related macular degeneration (AMD), a collection of conditions causing progressive blindness:
The researchers found 74% of the people with AMD had either the Factor H or Factor B risk factor or both - but no protective variants of either gene.
Lead researcher Dr Rando Allikmets said "I am not aware of any other complex disorder where nearly 75% of genetic causality has been identified.
"These findings are significant because they absolutely confirm the roles of these two genes and, consequently, the central role of a specific immune response pathway, in the development of AMD.
"In just a few short years, we've gone from knowing very little about what causes AMD to knowing quite a lot. We now have clear targets for early therapeutic intervention."
The researchers are now searching for the specific triggers that set off the immune response, and subsequent inflammation.
Considering that AMD is a catch-all category for many variant medical conditions, this is a surprising and pleasing finding. In this day and age of rapid research, a clear target for intervention is only a year of lab work away from good preliminary results in the development of a therapy.
Technorati tags: medical research
|
|
|
|
|
For all that a number of folk, myself included, don't see big government funding as the way forward for healthy life extension research, I think it's safe to predict increasing political engagement by the gerontology community on this topic. The advance of advocacy and plausible science backing radical life extension acts to bring the mainstream out of their conservative ways and into the realm of supporting modest healthy life extension of a few decades ... but at least they're willing to get to work on the problem now!
The mainstream of early stage science or basic research in most Western countries is heavily funded by government sources - perhaps 30% of total funding in the US, for example. Once the mainstream research community gets behind a particular idea, they'll seek to craft an environment that awards funding for related research. From there, support tends to spread out to more conservative patient advocate groups, and then out into the wider political ecosphere. At some point healthy life extension research will no doubt become yet another ball for politicians to misuse in their power games.
The gerontology and broader aging research community is sufficiently taken with modest healthy life extension - as of the moment, at least - that we'll soon be seeing organized attempts to engineer government funding. Admittedly, I get to hear these things a little in advance, but it shouldn't suprise anyone that initiatives of this sort are in the pipeline.
We are calling for a massive national and international effort to slow aging in humans under the premise that by doing so, humanity would reap a series of "Longevity Dividends" -- a gift to humanity from our generation to most current and all future generations. What is new here is the articulation of the "dividends" and the "target". I'll present this idea formally at the World Forum meeting in Oxford on the 15th of this month, but this is just the beginning of our effort to make this happen.
I'd say that by the end of 2007, the more forward-looking segments of the longevity research community will be obtaining fair-sized grants of public money as a result of two years of effort in the political arena.
Technorati tags: life extension, politics
|
|
|
|
|
(Via Frank at Anti-Aging Medicine and Science, who has a sharper eye than I for these things). The roving Congress of the International Association of Biomedical Gerontology (IABG) will next be held in 2007 in Greece, by the the look of it, under the auspices of the Institute of Biological Research and Biotechnology of the National Hellenic Research Foundation. This congress is titled "Molecular Mechanisms and Models of Ageing," and the Institute has a focus on systems biology:
The Institute of Biological Research and Biotechnology (IBRB) was established in 1977. The mission of the Institute is the acquirement of new knowledge in biological research and its socio-economic valorization, through biotechnological applications, the education of new researchers, the substantiated scientific documentation and information about the progress in biological research of the public and specific target groups (politicians, public and private organizations, press etc.)
...
Progress in Systems Biology, is crucial for a molecular understanding of many diseases and for development of novel biotechnological applications. The feedback between this iterative modelling and testing which is a key feature of Systems biology, to the study of diseases with a multi-factorial aetiology such as cancer and diabetes, will transform dramatically biology and medicine in the 21st century, radically modifying therapeutic practices and developing new ones (predictive, preventive and personalized medicine).
You might recall that Leroy Hood - of the Institute for Systems Biology in the US - believes this field is the path to 10-20 year healthy life extension over the next 20 years of research. This would come about through general improvements to medical and biotechnological capabilities across the board, not through any great sea change in the way the medical and research community address the mechanisms of aging.
The 11th congress of the IABG took place last August in Denmark. The 10th congress was held in the UK back in 2003, organized by biomedical gerontologist and healthy life extension advocate Aubrey de Grey:
The purpose of the IABG is (1) to make the general public more aware of the potential of biomedical aging research to increase the span of healthy productive life and to decrease the social and economic problems of age; and (2) to promote greater communication among the worldwide community of individuals engaged in biomedical aging research.
Mark your calendars accordingly.
Technorati tags: aging, conference, gerontology, life extension
|
|
|
|
|
Economic ignorance, willful or otherwise, is the death of cultures. The systematic destruction of incentives for progress - engineered by those who do not care to realize they are pulling the house down around their ears - will be the death of you and I as well if it continues. If we permit the ignorant to rule over medicine and medical research, destroying it in the process, then we deserve our fate:
A plan to outlaw private health insurance in California has been proposed by state Sen. Sheila Kuehl (D-Los Angeles). Senator Kuehl's bill, SB840, proposes to create the California Health Insurance Agency, a state government run single payer system for financing the health care of all Californians. Her bill, if enacted, would abolish all private health insurance in the Golden State.
...
Remarkably, Kuehl's proposal to socialize California's health care is being made just at the time when the Canadian system it resembles is falling apart at the seams. For instance, Canada's single payer system is projected to absorb more than half the budgets of most Canadian provinces. In addition, the amount of time a Canadian patient must wait before receiving medical care is notorious. "This is a country in which dogs can get a hip replacement in under a week and in which humans can wait two to three years," said Dr. Brian Day in a recent New York Times article on Canada's health care crisis.
Looking at the fine print, you find that Kuehl's government-run single payer system will be cheaper because it will actually ration health care. In other words, decisions about what treatments will be available to Californians and when they will become available will be in the hands of government health care bureaucrats. Just like the Canadian socialized health care system, the new California Health Insurance Agency will determine how much it will pay pharmaceutical companies for new more effective medicines. This means that Californians, like Canadians today, will wait a long time, possibly forever, to get access to modern therapies.
...
Doctors are like anybody else; they work less when they get paid less. If Kuehl's system is adopted, you will eventually see waiting lines lengthening and doctors treating fewer and fewer patients. California doctors and other health care workers will leave for other states where they are better compensated, and few new doctors, nurses and other personnel will be attracted to California. Another side effect will be that many of California's innovative biotech companies will relocate to friendlier business environments.
...
Today, as the Canadian health care system implodes, more and more Canadians are seeking private medical care across the border in the United States. Within a decade after Kuehl's single payer system has been adopted, I predict that many Californians will similarly be fleeing across the border into Arizona and Nevada looking for modern private medical care in state-of-the-art hospitals and clinics.
Why put your life and health into the hands of people who have no interest in helping you? Why think that socialism in medicine will work this time, when it has failed miserably everywhere else? As time moves on, those of us reading this now will become increasingly reliant on the new medical technologies of healthy life extension for health and longevity. If the future of medicine is socialist, then we won't be seeing much of that future - the destruction socialism and centralized, regulated systems bring to research and progress will see to that.
Technorati tags: libertarian, life extension, medicine
|
|
|
|
|
As I have outlined in the recent past, I think that toning down and self-censoring advocacy for radical life extension is a really bad idea. It does no good to remove instances of a suitable outrageous extreme from the discussion; rather, this makes it harder to direct support and resources towards plausible healthy life extension research.
Is there a way to be both moderate and an effective advocate for healthy life extension? I'm not convinced, but if there was a way to make it work, it might look something like this:
Greater knowledge about aging should bring better management of the debilitating pathologies associated with aging, such as cancer, cardiovascular disease, type II diabetes, and Alzheimer's. Therapies targeted at the fundamental mechanisms of aging will be instrumental in counteracting these age-related pathologies.
Therefore, this letter is a call to action for greater funding and research into both the underlying mechanisms of aging and methods for its postponement. Such research may yield dividends far greater than equal efforts to combat the age-related diseases themselves. As the mechanisms of aging are increasingly understood, increasingly effective interventions can be developed that will help prolong the healthy and productive life-spans of a great many people.
Personally, I find it hard, sometimes, to understand just why longevity is such a hard sell. Pick one: a) suffer and die before your time, or b) live a long, healthy, active life. Why, in a world in which longevity is much admired, do so many people reflexively chose option (a)?
Technorati tags: advocacy, life extension
|
|
|
|
|
Most people presently in middle age or early old age in developed regions of the world are going to have the opportunity to live longer than they presently expect. They haven't been paying close attention to trends in science and research. If we advocates of SENS and similar strategies have our way, the purposeful advance of biotechnology will deliver potential additional decades of healthy life, ever more as time moves on - but at a fair cost.
At some point, most folk have had the effects of compound interest on invested savings dramatically illustrated by example. A ten year difference between the date of initial savings is a very real difference to your purchasing power down the line - it doesn't take much of a rate of return on your investments to make that difference a factor of two. You'll need that purchasing power for newly commercialized anti-aging therapies - medical technology that actually repairs age-related cellular damage in vital organs. But so what? More healthy, vital years beat out just about anything else you could be doing with your savings.
Look at the wealthiest folk you know: real wealth, and the freedom it brings, is in the form of savings and investments, not income. You're going to have the opportunity to live healthily for longer than you think - which means more compound interest and an even greater reason to save aggressively now. So liberate the self you'll be three decades from now - it's within your power.
Technorati tags: personal finance
|
|
|
 |